NorthWest Biotherapeutics Inc (NWBO)

[RPD60]

Momentum, Keytruda is worth about 35% of Merck's market cap as it contributes 35% of Mercks revenue

Merck is $270B market cap so Keytruda is worth about 35% of $270B or $95B

If NWBO should become worth that much (ie $95B), then stock price would be about $56 ps assuming 1.7B shares.

However, the DC Vax platform technology is applicable to ALL cancers so $95B should (theoretically) be the low end

Hence, my $42per share estimate is neither ridiculous or irrational